Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEVG.L Share News (EVG)

  • There is currently no data for EVG

Record breaking year at Evolution

Thu, 25th Mar 2010 08:25
2009 was a record breaking year on many fronts for investment management firm Evolution Group.Group income, private client income, investment banking income and assets under management all hit new highs.Total income more than doubled to £129.4m in 2009 from £63.9m, with investment banking income soaring 183% to £87m while private client income rose 23% to £42.4m.Assets under management jumped 37% to a record level of £5.2bn from £3.8bn the year before. Fund inflows at £322m were down from £550m the year before, but the number of private client accounts grew from 11,803 to 14,343. Statutory profit before tax was £11.1m, compared to a loss of £12.7m the year before. The company’s own adjusted profit before tax measurement showed profitability improving to £18,4m from £2.9m in 2008. ‘While activity levels last year remained depressed and investor sentiment proved highly sensitive to risk and volatility, the group nevertheless delivered an extremely impressive financial performance, with significant growth in both income and profit,’ said Martin Gray, chairman of Evolution.The final dividend has been increased by 34% to 1.70p, making the full year dividend 2.50p, up 24% on 2008’s level.

Related News

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well
25 Apr 2024

TRADING UPDATES: Norcros sells Johnson Tiles UK; Trifast trading well

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests
4 Apr 2024

TRADING UPDATES: Northcoders launches bootcamp; Schroder invests

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News:

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat
19 Mar 2024

EARNINGS AND TRADING: Ten Lifestyle sees profit up but sales flat

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reporte...

EVG.L News

TRADING UPDATES: Synectics loss narrows; Active Energy loss widens
14 Jun 2021

TRADING UPDATES: Synectics loss narrows; Active Energy loss widens

TRADING UPDATES: Synectics loss narrows; Active Energy loss widens

Evgen upbeat on new data on potential breast cancer treatment
14 Jun 2021

Evgen upbeat on new data on potential breast cancer treatment

(Sharecast News) - Clinical-stage drug development company Evgen Pharma announced new preclinical data on Monday, which showed 'SFX-01' could be of be...

IN BRIEF: Evgen Pharma appoints Huw Jones as chief medical officer
26 Apr 2021

IN BRIEF: Evgen Pharma appoints Huw Jones as chief medical officer

IN BRIEF: Evgen Pharma appoints Huw Jones as chief medical officer

IN BRIEF: Evgen Pharma notes publication on sulforaphane in Covid-19
7 Apr 2021

IN BRIEF: Evgen Pharma notes publication on sulforaphane in Covid-19

IN BRIEF: Evgen Pharma notes publication on sulforaphane in Covid-19

IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer
22 Mar 2021

IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer

IN BRIEF: Evgen Pharma names Helen Kuhlman as chief business officer

Evgen appoints Helen Kuhlman as chief business officer
22 Mar 2021

Evgen appoints Helen Kuhlman as chief business officer

(Sharecast News) - Clinical-stage drug development company Evgen announced on Monday that Helen Kuhlman had been appointed to the post of chief busine...

IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial
11 Mar 2021

IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial

IN BRIEF: Evgen says no patient safety concerns in STAR Covid-19 trial

Evgen Covid-19 trial given all-clear on safety and data
11 Mar 2021

Evgen Covid-19 trial given all-clear on safety and data

(Sharecast News) - Clinical stage drug development company Evgen Pharma announced on Thursday that after a review of the first 60 patients enrolled, t...